Cxbladder for Patients
New Section Page
Use in Surveillance
New New Blocks Page
Cxbladder's Clinical Utility in Focus at AUA 2025
Recognition of Cxbladder’s clinical and economic value in evaluating patients presenting with hematuria is set to gain momentum at the American Urological Association’s (AUA) Annual Meeting,... read more
Cxbladder Bulletin - April 2025
Pacific Edge invites you to read the April 2025 edition of our Cxbladder Bulletin clinician newsletter. In this issue: Cxbladder Incorporated into AUA Clinical Guideline SESAUA... read more
Medicare Coverage Update for US Cxbladder Customers
An important update for all US Cxbladder Customers, *Executive summary:* Novitas has finalized an LCD for Genetic Testing in Oncology that removed coverage for Medicare beneficiaries... read more
May is Bladder Cancer Awareness Month 2025
Every year, over 610,000 people are diagnosed with bladder cancer around the world, and more than 1.9 million people are living with and beyond bladder cancer.... read more
Cxbladder Bulletin - July 2025
Pacific Edge invites you to read the July 2025 edition of our Cxbladder Bulletin clinician newsletter. In this issue: - *Watch Now:* View Videos From the UroToday... read more
Clinical Value of Cxbladder to Feature at UAA 2025
New clinical evidence demonstrating Cxbladder’s clinical value in hematuria evaluation and surveillance – including reducing unnecessary procedures and better outcomes for patients - is set to... read more